ImageneBio, Inc.
Develops therapeutics for immunological, autoimmune, and inflammatory diseases.
IMA | US
Overview
Corporate Details
- ISIN(s):
- US45175G1085
- LEI:
- Country:
- United States of America
- Address:
- 12526 HIGH BLUFF DRIVE, 92130 SAN DIEGO
- Website:
- https://inmagenebio.com/
- Sector:
- Manufacturing
Description
ImageneBio, Inc. is a clinical-stage biotechnology company that develops therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company's lead candidate is IMG-007, a next-generation investigational anti-OX40 monoclonal antibody. IMG-007 is designed with an extended half-life to target and inhibit OX40 receptor signaling without depleting T cells, aiming to provide a potential best-in-class treatment with enhanced efficacy, safety, and patient convenience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ImageneBio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ImageneBio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ImageneBio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
